BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16973959)

  • 1. Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta.
    Zhu J; Martinez J; Huang X; Yang Y
    Blood; 2007 Jan; 109(2):619-25. PubMed ID: 16973959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internalization and TLR-dependent type I interferon production by monocytes in response to Toxoplasma gondii.
    Han SJ; Melichar HJ; Coombes JL; Chan SW; Koshy AA; Boothroyd JC; Barton GM; Robey EA
    Immunol Cell Biol; 2014 Nov; 92(10):872-81. PubMed ID: 25155465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate Immune Signaling Contributes to Tubular Cell Senescence in the Glis2 Knockout Mouse Model of Nephronophthisis.
    Jin H; Zhang Y; Liu D; Wang SS; Ding Q; Rastogi P; Purvis M; Wang A; Elhadi S; Ren C; Cao C; Chai Y; Igarashi P; Jetten AM; Lu D; Attanasio M
    Am J Pathol; 2020 Jan; 190(1):176-189. PubMed ID: 31676329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome.
    Delaloye J; Roger T; Steiner-Tardivel QG; Le Roy D; Knaup Reymond M; Akira S; Petrilli V; Gomez CE; Perdiguero B; Tschopp J; Pantaleo G; Esteban M; Calandra T
    PLoS Pathog; 2009 Jun; 5(6):e1000480. PubMed ID: 19543380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring HIV Vaccine Progress in the Pre-Clinical and Clinical Setting: From History to Future Prospects.
    Kaur A; Vaccari M
    Viruses; 2024 Feb; 16(3):. PubMed ID: 38543734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Chemokine CXCL14 as a Potential Immunotherapeutic Agent for Cancer Therapy.
    Giacobbi NS; Mullapudi S; Nabors H; Pyeon D
    Viruses; 2024 Feb; 16(2):. PubMed ID: 38400076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoinformatics and reverse vaccinology approach in designing a novel highly immunogenic multivalent peptide-based vaccine against the human monkeypox virus.
    Choudhury A; Chandra A; Dawoud TM; Nafidi HA; Singh N; Bourhia M
    Front Mol Biosci; 2023; 10():1295817. PubMed ID: 38074091
    [No Abstract]   [Full Text] [Related]  

  • 8. An MVA-based vector expressing cell-free ISG15 increases IFN-I production and improves HIV-1-specific CD8 T cell immune responses.
    Falqui M; Perdiguero B; Coloma R; Albert M; Marcos-Villar L; McGrail JP; Sorzano CÓS; Esteban M; Gómez CE; Guerra S
    Front Cell Infect Microbiol; 2023; 13():1187193. PubMed ID: 37313341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-encoded nanoparticle vaccine platforms for in vivo assembly of multimeric antigen to promote adaptive immunity.
    Tursi NJ; Xu Z; Kulp DW; Weiner DB
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(4):e1880. PubMed ID: 36807845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-Epitope Vaccine Design against Monkeypox Virus via Reverse Vaccinology Method Exploiting Immunoinformatic and Bioinformatic Approaches.
    Bhattacharya K; Shamkh IM; Khan MS; Lotfy MM; Nzeyimana JB; Abutayeh RF; Hamdy NM; Hamza D; Chanu NR; Khanal P; Bhattacharjee A; Basalious EB
    Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poxviruses and the immune system: Implications for monkeypox virus.
    Saghazadeh A; Rezaei N
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109364. PubMed ID: 36283221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmacytoid dendritic cells during COVID-19: Ally or adversary?
    Van der Sluis RM; Holm CK; Jakobsen MR
    Cell Rep; 2022 Jul; 40(4):111148. PubMed ID: 35858624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression profile and in-silico functional analysis of long noncoding RNA and mRNA in duck embryo fibroblasts infected with duck plague virus.
    Wu Z; Zeng Y; Cheng A; Sun A; Wang M; Chen S; Liu M; Zhu D; Zhao X; Wu Y; Yang Q; Zhang S; Huang J; Ou X; Gao Q; Mao S; Sun D; Tian B; Zhang L; Yin Z; Jia R
    BMC Genomics; 2022 Jul; 23(1):509. PubMed ID: 35836133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression.
    Giurini EF; Madonna MB; Zloza A; Gupta KH
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orf Virus-Based Vectors Preferentially Target Professional Antigen-Presenting Cells, Activate the STING Pathway and Induce Strong Antigen-Specific T Cell Responses.
    Müller M; Reguzova A; Löffler MW; Amann R
    Front Immunol; 2022; 13():873351. PubMed ID: 35615366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials.
    Fischinger S; Cizmeci D; Deng D; Grant SP; Frahm N; McElrath J; Fuchs J; Bart PA; Pantaleo G; Keefer M; O Hahn W; Rouphael N; Churchyard G; Moodie Z; Donastorg Y; Streeck H; Alter G
    PLoS Pathog; 2021 Nov; 17(11):e1010016. PubMed ID: 34843602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines.
    Sartorius R; Trovato M; Manco R; D'Apice L; De Berardinis P
    NPJ Vaccines; 2021 Oct; 6(1):127. PubMed ID: 34711839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like Receptors in Viral Encephalitis.
    Gern OL; Mulenge F; Pavlou A; Ghita L; Steffen I; Stangel M; Kalinke U
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. γδT Cells Are Required for CD8
    Dai R; Huang X; Yang Y
    Front Immunol; 2021; 12():727046. PubMed ID: 34691033
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.